Stryker Snaps Up Mako

Mako Surgical Corp. is one of today’s bigger fish in robotic surgery, although it’s had to overcome some choppy waters to get here. Now Stryker has got its teeth into the Florida based robot-assisted knee joint resurfacing outfit, to the tune of a $1.65Bn takeover.

Bard Makes Presence Felt in Hemostat Market with Medafor Acquisition

C. R. Bard, Inc. is to acquire privately-held Medafor, Inc., a leading developer and supplier of plant based hemostatic agents. The purchase price of $200 million will be paid at closing, expected to occur later this year, and future contingent payments up to an additional $80 million are based on specific revenue-based milestones through June 30, 2015.

Most read

Latest

^